ストックスクリーナーアプリを入手
10.08
2.54%
0.25
前日終値:
$9.83
開ける：
$9.86
24時間の取引高:
38,330
Relative Volume:
0.93
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+4.46%
1か月 パフォーマンス:
-6.67%
6か月 パフォーマンス:
-6.93%
1年 パフォーマンス:
-3.58%
1日の値動き範囲:
$9.81
$10.09
1週間の範囲:
$9.52
$10.09
52週間の値動き範囲:
$9.52
$12.53
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
GNOM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| GNOM | 10.08 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 296.51 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 595.51 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 598.45 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 257.73 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 505.79 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf (GNOM) 最新ニュース
When (GNOM) Moves Investors should Listen - Stock Traders Daily
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
Newport Capital Group LLC Acquires Shares of 21,305 iShares 3-7 Year Treasury Bond ETF (NASDAQ:IEI) - Defense World
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
Top Canadian Genetics Stocks of 2024 - The Motley Fool Canada
How To Avoid The Worst Sector ETFs 3Q24 - Forbes
Investing in Nobel Prize Achievements – CRISPR For Precise Genetic Engineering - Securities.io
(GNOM) Proactive Strategies - Stock Traders Daily
3 Gene Editing Stocks with Potential to Transform Medicine - InvestorPlace
BioTech & Genomics ETFs Shine Amid Sector Rotation - Trackinsight
Time for Healthcare ETFs? - Yahoo Finance
Biotech ETFs See Uptick Amid Positive Market Signs - Trackinsight
The 3 Best Gene Editing Stocks to Buy in July 2024 - InvestorPlace
4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Investing.com
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
7 Best Biotech ETFs to Buy Now | Investing - U.S News & World Report Money
The Next Big Theme: June 2024 - Global X
How To Trade (GNOM) - Stock Traders Daily
Top Sector ETFs From Wall Street's Best Week in 3 Months - Yahoo New Zealand News
Why this money manager is shoring up cash and buying into commodities, genomics and Mexico - The Globe and Mail
5 Small-cap Biotech ETFs to Watch (Updated 2024) | INN - Investing News Network
When the Price of (GNOM) Talks, People Listen - Stock Traders Daily
Where are the Opportunities in (GNOM) - Stock Traders Daily
Private Advisor Group LLC Lowers Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Beyond Ordinary Model Portfolios - Global X
Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Rises By 69.1% - Defense World
Profit from the Genomics Market Momentum With These ETFs - Yahoo Movies UK
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life - InvestorPlace
Genomics ETF (GNOM) Hits New 52-Week High - Yahoo Lifestyle UK
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire - InvestorPlace
(GNOM) Technical Data - Stock Traders Daily
In the Pipeline: Top Drug Candidates for FDA Approval in 2024 - Nasdaq
The Next Big Theme: April 2024 - Global X
9 Best Biotech ETFs for 2024 - GOBankingRates
Investing in Pharma: How to Spot Leading Drug Candidates - Global X
CTNM Stock: Discover Biotech Investing Potential with Contineum Therapeutics - Value the Markets
Genomics and the Future of Healthcare Diagnostics – Global X ETFs - Global X
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment (NASDAQ:GNOM) - Seeking Alpha
3 Stocks That Could Be the Next Big Thing in Gene Editing - InvestorPlace
The Next Big Theme: March 2024 - Global X
Why Gene Editing Could Be Worth $120 Billion by 2027 - Opto RoW
Biotech Funds Underperform the Broader Market - Trackinsight
Video: Give Someone a Fish, You Feed Them—Unlock the Fish - CSRwire.com
Gene Therapy: A Cure for Cancer? - Opto RoW
Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 ... - Nature.com
The Next Big Theme: February 2024 – Global X ETFs - Global X
Genomic data in the All of Us Research Program - Nature.com
3 Gene Editing Stocks With Unprecedented Surge Potential - Yahoo Finance
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential - InvestorPlace
The Next Big Theme: January 2024 - Global X
Two industries where Einstein would invest - Finimize
Global X Genomics Biotechnology Etf (GNOM) 財務データ
Global X Genomics Biotechnology Etf (GNOM) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.73%
大文字化:
|
ボリューム (24 時間):